https://www.avient.com/resources/safety-data-sheets?page=7159
X-AR-444872A-1
https://www.avient.com/news/polyone-accentuates-what’s-possible-application-specific-materials-and-design-npe-2018
Properties that can be achieved with these materials include transparency, even for formulations based on polysulfone, electrical and/or thermal conductivity, laser marking, and X-ray opacity.
https://www.avient.com/resources/safety-data-sheets?page=7202
X 41906-0009A-02-1
https://www.avient.com/resources/safety-data-sheets?page=72
X Trilliant HC6600-0021 Metallic Blue
https://www.avient.com/news/polyone-debuts-latest-healthcare-solutions-mdm-west-2015
Radiopaque translucent catheters: NEU™ View Radiopaque Translucent Solutions offer catheter producers an enhanced technology that provides excellent visibility, both optically and under X-ray, boosting clinician confidence and patient comfort.
https://www.avient.com/news/polyone-design-and-innovation-solutions-take-center-stage-chinaplas-2019
GUANGZHOU, China – May 21, 2019 – At CHINAPLAS 2019 this week, PolyOne is sponsoring Design X Innovation, three events co-located at the fairgrounds that offer inspiration for product designs.
https://www.avient.com/sites/default/files/2020-10/luxury-closures-gravi-tech-design-guide-2.0-application-specific.pdf
CHAPTER 1 | APPLICATION SUMMARY Design Guide 5 GRAVI-TECH GT5200-0013 GRAVI-TECH GT6000-0004 GRAVI-TECH GT7300-0006 GRAVI-TECH GT5200-5003 GRAVI-TECH GT6000-5002 GRAVI-TECH GT7300-5007 Specific Gravity* 2.0 3.0 2.0 2.5 2.6 2.2 Color Options* Various Various Black to Grey Black Various Various Electroplating No Possibly Yes Possibly Possibly Yes Base Resin PP PA6 ABS PP PA6 ABS FDA Compliant* Yes Yes Yes Yes No Yes Region Produced North America North America North America Europe Europe Europe Full Name X GT5200-0013 PT White X GT6000-0004 PT White X GT7300-0006 PT Black GT7300-5003 Black FD GT6000-5002 EI White 1 GT7300-5007 X2 White FD *Please contact Avient for additional information 6 Gravi-Tech CHAPTER 2 | PROCESS SETTINGS Density Modified Formulations Gravi-Tech™ polymer-metal composites are high-density materials developed as thermoplastic- based alternatives to metals.
This will result in stronger parts due to the locked in FIGURE 43 - Non-Newtonian Fluid Flow Low Level of Orientation Frozen Layer Highly Oriented Laminates Gate Pressure Transducer A Pressure Transducer B Hydraulic x 10 Filling Hold Start of mold shrinkage Time Pack P re ss u re A B FIGURE 45 - Non-Newtonian fluid flow Relative Viscosity = Transfer Position * Fill Time Shear Rate = 1 Fill time FIGURE 46 - Pressure vs.
The modulus of steel is 3 x 107 psi. • Area = πr2 • Stress (σ) = Force (F) / Area (A) • Strain (¤) = Stress (σ) / Modulus ( E ) • Change in Length (ΔL) = Length (L) * Strain (¤) MOLD DESIGN GUIDELINES Layout Design A & B Plate thicknesses are determined by the depth of the part geometry plus 3 times the water line thickness (Usually .375").2 Support Plate Thickness Use recommended plate from mold base selection, add support pillars if deflection or stress is too high.
https://www.avient.com/sites/default/files/2020-08/avient-investor-presentation-jefferies-industrials-conference.pdf
Avient Corporation 1 JEFFERIES VIRTUAL INDUSTRIALS CONFERENCE A U G U S T 2 0 2 0 Avient Corporation 2 FORWARD LOOKING STATEMENTS • • • • • • • • • • • • • • • • • • • • Avient Corporation 3 USE OF NON-GAAP MEASURES • • • Avient Corporation 4 UPDATE ON THE COVID-19 PANDEMIC • • • • Avient Corporation 5 2019 Transportation Consumer Discretionary Healthcare Packaging All Other Industries Cost Containment FX 2020 $64.3 18% 18% 9% 6% 16% 2% $46.9 20% • • • • • • SECOND QUARTER 2020 IN REVIEW Consumer Discretionary Avient Corporation 6 CLARIANT MASTERBATCH STRATEGIC RATIONALE Avient Corporation 7 FIT W I T H FOUR PILLAR S T R A T E G Y Specialization • • • Globalization • • Operational Excellence • • • Commercial Excellence • • People Avient Corporation 8 5% 2006 2019E PF* 4% 12% 10% 18% 8% 20% 2006 2019E PF* Healthcare Consumer Packaging 38% * 2019E Pro Forma for PP&S Divestiture and Clariant Masterbatch business Percentage of Total Revenue E N D M A R K E T T R A N S F O R M A T I O N Building & Construction High Growth End Markets 50% 22% Avient Corporation 9 Wire & Cable 11% Industrial 10% Electrical & Electronic 7% Healthcare 4% Packaging 8% Consumer 10% Transportation 12% Building & Construction 38% Healthcare 12% Packaging 20% Consumer 18%Transportation 12% Building & Constrution 5% Wire & Cable 9% Industrial 11% Electrial & Electronic 4% Appliance 2% Textiles 7% 2006 Pro Forma(1) Net Sales by End Market E N D M A R K E T T R A N S F O R M A T I O N Avient Corporation 10 U N I F I E D F O C U S O N S U S T A I N A B I L I T Y 2006 - 2013 2013 – 2019 PEOPLE PROD UC TS PLANET PER FOR M A NC E •• •• •• Avient Corporation 11 O V E R 8 5 % O F A D J U S T E D E B I T D A F R O M S P E C I A L T Y 46% 66% 0% 20% 40% 60% 80% 100% 2005 2010 2015 Pro Forma % o f A d ju s te d E B IT D A ( 1) JVs Performance Products & Solutions Distribution Specialty 7% 87% (2) Avient Corporation 12 T H E N E W A V I E N T : A S P E C I A L T Y G R O W T H C O M P A N Y Transaction expected to add $0.85 to pro forma adjusted EPS Avient Corporation 13 SUSTAINABILITY AT AVIENT P E O P L E , P R O D U C T S , P L A N E T , P E R F O R M A N C E Avient Corporation 13 Avient Corporation 14 V I S I O N To be the world’s premier provider of specialized polymer materials, services and solutions C O R E V A L U E S P E R S O N A L V A L U E S Honesty IntegrityRespect Operational Excellence Commercial Excellence Specialization Globalization Collaboration ExcellenceInnovation To be the world’s premier provider of specialized polymer materials, services and sustainable solutions Avient Corporation 15 1.3 1.1 1.1 0.85 0.65 0.57 0.54 0.97 0.84 0.74 0.74 0.69 0.51 0.56 0.14 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 YTD S A F E T Y F I R S T Injuries per 100 Workers Spartech Acquisition Avient Corporation 16 G R E A T P L A C E T O W O R K Avient Corporation 17 C O M M O D I T Y T O S P E C I A L T Y T R A N S F O R M A T I O N • • • • • • • • • • • • 2006 - 2013 2013 – 20192000-2005 2006 - 2013 • • 2020 and Beyond Avient Corporation 18 A V I E N T 2 0 1 9 R E V E N U E | $ 2 . 9 B I L L I O N Segment End Market Geography Healthcare 15% Industrial 14% Consumer 14% Packaging 13% Transportation 13% Wire & Cable 11% Building & Construction 6% Electrical & Electronics 6% Textiles 5% Appliance 3% Color Additives & Inks 34% Distribution 41% Specialty Engineered Materials 25% United States 54% Europe 19% Asia 11% Latin America 11% Canada 5% Avient Corporation 19 Operating Income % of Sales 2006 2019 Color, Additives & Inks 1.7% 14.7% Specialty Engineered Materials 1.1% 11.6% Distribution 2.6% 6.3% 2009 2010 2011 2012 2013 2014 2015 2016*2017* 2018 $2.43 P R O O F O F P E R F O R M A N C E C O N S E C U T I V E Y E A R S 10 $0.13 $0.68 $0.82 $1.00 $1.31 $1.80 $1.96 $2.06 $2.21 A D J U S T E D E P S E X P A N S I O N 2018 2019 $1.69 $1.51 Avient Corporation 20 531 710 1,032 130 164 207 504 663 871 2014 2018 Pro Forma R&D / Technical Marketing Sales + 34% + 26% + 32% E X P A N S I O N O F COMMERCIAL RESOURCES D R I V I N G G R O W T H Revenue in Billions Total + 10% Organic + 7%+ 45% + 26% + 31% $4.0 $3.2 (2) (1) (1) $2.9 $2.9 $3.5 2015 2016 2017 2018 Pro Forma Total + 9% Organic + 5% Pro Forma(2) Avient Corporation 21 P R I O R A C Q U I S I T I O N S H I S T O R Y Commercial Resources(1) Operating Income ($ in millions) Operating Margins 256 350 At Acquisition 2019 $36 $100 At Acquisition 2019 9% 19% At Acquisition 2019 Established Acquisitions (> 7 years) + 37% + 176% + 1000 bps Avient Corporation 22 A L I G N I N G W I T H T R E N D S F O R G R O W T H T R A N S P O R T A T I O N P A C K A G I N G H E A L T H C A R E C O N S U M E R Facilitate alternative energy solutions Light- weighting Reduce packaging materials Improve recyclability Reduce spread of infection Avient Corporation 23 I N N O V A T I O N Customization 55% M&A 30% Innovation Pipeline 15% Innovation comes from Research & Development Spend Vitality Index 12% 37% 2006 2019 $20 $51 2006 2019 Avient Corporation 24 R E V E N U E F R O M S U S T A I N A B L E S O L U T I O N S $275M $325M $355M $410M 14% Total Annual Growth 9% Organic Annual Growth Avient Corporation 25 SEGMENT HIGHLIGHTS I N N O V A T I N G W I T H A V I E N T Avient Corporation 25 Avient Corporation 26 C O L O R , A D D I T I V E S & I N K S E N D M A R K E T S & S O L U T I O N S Solid Colorants Performance Additives Screen Printing Inks Liquid Colorants Packaging 31% Industrial 14% Textiles 13% Wire & Cable 10% Building & Construction 9% Consumer 8% Transportation 7% Healthcare 5% Appliances 2% Electrical & Electronics 1% Avient Corporation 26 Avient Corporation 27 Operating Income & MarginRevenue by Region C O L O R , A D D I T I V E S & I N K S 2 0 1 9 R E V E N U E | O V E R $ 1 B I L L I O N Europe 34% United States 44% Asia 15% Canada 1% Mexico 3% South America 3% $4 $25 $104 $147 2005 2009 2013 2019 0.9% 5.5% 12.2% 14.7% Avient Corporation 27 Avient Corporation 28 S P E C I A L T Y E N G I N E E R E D M A T E R I A L S E N D M A R K E T S & S O L U T I O N S Engineered Formulations Advanced Composites Thermoplastic Elastomers Wire & Cable* 28% Consumer 19% Electrical & Electronics 12% Healthcare 9% Industrial 8% Packaging 6% Appliance 2% Building & Construction 2% Transportation 14% Avient Corporation 28 Avient Corporation 29 S P E C I A L T Y E N G I N E E R E D M A T E R I A L S Revenue by Region Operating Income & Margin 2 0 1 9 R E V E N U E | $ 7 5 0 M I L L I O N Europe 27% United States 54% Asia 17% Canada 2% $21 $57 $87 2005 2009 2013 2019 0.1% 5.1% 9.3% 11.6% Avient Corporation 29 Avient Corporation 30 D I S T R I B U T I O N E N D M A R K E T S & S U P P L I E R S Healthcare 28% Industrial 19% Transportation 18% Consumer 17% Appliance 6% Electrical & Electronics 5% Building & Construction 4% Packaging 2% Wire & Cable 1% Operating Income & Margin2019 Revenue | $1.2 Billion $25 $63 $75 2005 2009 2013 2019 $20 2.9% 4.0% 5.9% 6.3% Avient Corporation 30 http://www.polyone.com/Pages/VariationRoot.aspx Avient Corporation 31 O V E R V I E W O F R A W M A T E R I A L P U R C H A S E S Avient Corporation 31 Avient Corporation 32 Avient Corporation 33 Adjusted EPS attributable to PolyOne common shareholders is calculated as follows: 2009* 2010* 2011* 2012* 2013* 2014* 2015* 2016** 2017** 2018 2018*** Q1 2019*** 2019 Q1 2020 Net income from continuing operations attributable to PolyOne common shareholders Joint venture equity earnings, after tax Special items, before tax (1) Special items, tax adjustments (1) Adjusted net income from continuing operations attributable to PolyOne common shareholders $ 106.7 $ 152.5 $ 153.4 $ 53.3 $ 94.0 $ 78.0 $ 144.6 $ 166.4 $ 173.5 $ 161.1 $ 87.7 $ 22.4 $ 75.5 $ 33.1 (19.0) (14.7) (3.7) — — — — — — — — — — — (48.7) 24.2 (48.1) 55.1 46.3 164.2 87.6 23.8 32.9 59.5 58.7 12.2 61.7 9.6 (27.2) (96.7) (24.7) (18.9) (13.7) (73.7) (58.7) (15.9) (24.8) (25.3) (25.1) (1.2) (5.9) (1.0) $ 11.8 $ 65.3 $ 76.9 $ 89.5 $ 126.6 $ 168.5 $ 173.5 $ 174.3 $ 181.6 $ 195.3 $ 121.3 $ 33.4 $ 131.3 $ 41.7 Diluted shares 93.4 96.0 94.3 89.8 96.5 93.5 88.7 84.6 82.1 80.4 80.4 78.2 77.7 86.7 Adjusted EPS attributable to PolyOne common shareholders $ 0.13 $ 0.68 $ 0.82 $ 1.00 $ 1.31 $ 1.80 $ 1.96 $ 2.06 $ 2.21 $ 2.43 $ 1.51 $ 0.43 $ 1.69 $ 0.48 * Historical results are shown as presented in prior filings and have not been updated to reflect subsequent changes in accounting principle, discontinued operations or the related resegmentation. ** Pro forma for sale of Designed Structures and Solutions segment (DSS). *** Pro forma for sale of Performance Products and Solutions segment (PP&S).
https://www.avient.com/sites/default/files/resources/Innovation%2520Day%2520-%2520May%25202014.pdf
CT scanners) Creates value by eliminating the need for machining and secondary operations, removing weight, streamlining production and improving cost efficiencies PolyOne Corporation Page 52 Medical Device Solutions Catheters made using NEU™ View patent-pending technology are optically translucent, and have superior contrast under X-ray (radiopaque) when compared with alternative catheter materials Formulations for cardiovascular and intravascular catheters are application-specific, incorporating medical-grade polymers, additives, color, and healthcare-centric manufacturing practices Only commercially available product that has excellent visibility, both optically and under X-ray, to bolster clinician confidence and offer significant market advantage PolyOne Corporation Page 53 Consumer Electronics Solutions Ability to offer multiple technology solutions on a global basis for this industry, where many OEMs design in one region, prototype in another, and manufacture in yet another Sustainable / “green” solutions help customers to differentiate in this market New formulations for emerging wearables market that meet skin contact requirements and aesthetic needs PolyOne Corporation Page 54 Appliances 4% Building & Construction 4% Consumer 17% Electrical & Electronics 16% Healthcare 12% Industrial 8% Packaging 7% Transportation 19% Wire & Cable 13% At a Glance Global Specialty Engineered Materials 2013 Revenues: $0.6 Billion Solutions 2013 Revenue by Industry Segment Expanding Profits 1.1% 1.3% 3.4% 5.1% 9.6% 8.0% 8.6% 9.3% 12-16% 2006 2007 2008 2009 2010 2011 2012 2013 Q1 2014 2015 Operating Income % of Sales Target United States 43% Europe 33% Canada 2% Asia 18% Latin America 4% 11.6% PolyOne Corporation Page 55 Appliances 2% Building & Construction 11% Consumer 5% Electrical & Electronics 6% Healthcare 7% Industrial 13% Packaging 34% Transportation 10% Wire & Cable 12% Target At a Glance Global Color, Additives and Inks 2013 Revenues: $0.9 Billion Solutions Expanding Profits 1.7% 4.6% 5.1% 5.5% 7.2% 8.1% 9.7% 12.2% 12-16% 2006 2007 2008 2009 2010 2011 2012 2013 Q1 2014 2015 Operating Income % of Sales United States 44% Europe 37% Canada 2% Asia 11% Latin America 6% 2013 Revenue by Industry Segment 13.8% PolyOne Corporation Page 56 At a Glance Designed Structures and Solutions Solutions 2013 Revenues: $0.6 Billion Expanding Profits 2.2% 8 - 10% 6.5% 2012 PF Q1 2013 Q1 2014 2015 Operating Income % of Sales 0.2% Target United States 96% Canada 3% Latin America 1% Appliances 2% Building & Construction 10% Consumer 11% Healthcare 6% Industrial 13% Packaging 32% Transportation 26% 2013 Revenue by Industry Segment PolyOne Corporation Page 57 5.5% 6.9% 3.8% 3.6% 5.5% 4.3% 6.3% 7.2% 2006 2007 2008 2009 2010 2011 2012 2013 Q1 2014 Operating Income % of Sales At a Glance Performance Products and Solutions Solutions Expanding Profits 2013 Revenues: $0.8 Billion United States 81% Europe 1% Canada 14% Asia 2% Latin America 2% 9-12% Target 2013 Revenue by Industry Segment Appliances 8% Building & Construction 34% Consumer 4% Electrical & Electronics 3% Healthcare 1%Industrial 10% Packaging 6% Transportation 16% Wire & Cable 18% 2015 7.7% PolyOne Corporation Page 58 2.6% 3.0% 3.5% 4.0% 4.6% 5.6% 6.4% 5.9% 6 - 7.5% 2006 2007 2008 2009 2010 2011 2012 2013 Q1 2014 2015 Operating Income % of Sales 15.3% 46.0% 2006 Q1 2014 At a Glance Distribution *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period Solutions 2013 Revenues: $1.1 Billion ROIC* Expanding Profits Target Appliances 5% Building & Construction 5% Consumer 14% Electrical & Electronics 5% Healthcare 24% Industrial 16% Packaging 5% Transportation 23% Wire & Cable 3% 6.1% http://www.polyone.com/Pages/VariationRoot.aspx
https://www.avient.com/sites/default/files/2024-03/AVNT February IR Presentation_w_Non-GAAP Recs_v2.pdf
PY (TOTAL COMPANY) $790 $719 2022 2023 $107 $114 2022 2023 Sales Adjusted EBITDA (in millions) $0.42 $0.52 2022 2023 Adjusted EPS (in millions) - 9% + 7% + 24% Sales Adjusted EBITDA Adjusted EPS 15 Q4 2023 SEGMENT PERFORMANCE 16 CAI $491 $459 Sales (in millions) $70 $84 EBITDA SEM $301 $260 Sales $55 $49 EBITDA - 7% - 14%+20% - 11% 2022 2023 (in millions) Q4 EBITDA BRIDGE (TOTAL COMPANY) 17 $ millions CAI: Price / Mix 11 Deflation 14 SEM: Price / Mix 4 Deflation 9 Net Price Benefit 38 Cost Reductions 13 Wage Inflation (8) Other (2) Q4 2023 $114 Adjusted EBITDA Q4 2022 $ 107 Demand (34) • Demand was down, but less than in previous quarters, due to slowing pace of destocking • Positive net price benefit: o CAI – Pricing flat with favorable mix from uptick in packaging and consumer end markets and raw material deflation o SEM - Pricing flat with favorable mix from Composites and raw material deflation • Cost reductions primarily driven by reduced administrative costs and cost synergies 2024 G U I DAN CE 2024 GUIDANCE Full Year 2024 Guidance Adjusted EBITDA $505 to $535 million Adjusted EPS $2.40 to $2.65 Interest Expense $105 to $110 million Adjusted Effective Tax Rate 23% to 25% Capital Expenditures ~$140 million 19 Q1 Adjusted EPS of $0.68 AP P E N DI X 21 Performance Additives 15% Pigments 13% TiO2 9% Dyestuffs 2% Polyethylene 10%Nylon 5% Polypropylene 4% Styrenic Block Copolymer 4% Other Raw Materials 38% ~40% hydrocarbon based (Grey shaded materials are hydrocarbon based, includes portion of “Other Raw Materials”) Non-hydrocarbon based materials RAW MATERIAL BASKET SEGMENT DATA U.S. & Canada 41% EMEA 36% Asia 18% Latin America 5% 2023 SEGMENT, END MARKET AND GEOGRAPHY GEOGRAPHY REVENUESEGMENT FINANCIALS Consumer 19% Packaging 23%Industrial 16% Building and Construction 9% Telecommunications 4% Energy 5% Defense 7% END MARKET REVENUE $2,007M $358M $1,138M $224M Sales EBITDA Specialty Engineered Materials Color Additives and Inks $502M$3,143M (1) Transportation 10% Healthcare 7% 23 (1) Total company sales and adjusted EBITDA of $3,143M and $502M, respectively, include intercompany sales eliminations and corporate costs 2023 REVENUE | $2 .0 BILLION US & Canada 34% EMEA 37% Asia 21% Latin America 8% END MARKET REGION 24 Packaging 34% Consumer 21% Healthcare 8% Industrial 15% Transportation 9% Building & Construction 10% Telecommunications 1% Energy 2% COLOR, ADDITIVES & INKS 2023 REVENUE | $1 .1 BILLION US & Canada 52% EMEA 35% Asia 13% 25 Packaging 5% Consumer 16% Healthcare 6%Industrial 16% Transportation 12% Telecommunications 9% Energy 10% Defense 18% Building & Construction 8% END MARKET REGION SPECIALTY ENGINEERED MATERIALS Packaging 32% Consumer 26% Healthcare 9% Industrial 13% Building & Construction 6% Telecommunications 2% Energy 2% Defense 1% Asia (18% of sales) Transportation 9% 2023 AVIENT REGIONAL SALES Packaging 25% Consumer 13% Healthcare 5% Industrial 18% Building & Construction 9% Energy 5% Defense 8% EMEA (36% of sales)Transportation 13% Packaging 13% Consumer 22% Healthcare 10% Industrial 16% Building & Construction 12% Energy 6% Defense 8% US & Canada (41% of sales) Transportation 9% Packaging 59% Consumer 22% Healthcare 2% Industrial 8% Building & Construction 4% LATAM (5% of sales) Transportation 5% Telecommunications 4% Telecommunications 4% 26 BY END MARKET Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except for per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results.